Figure 2.
NSAA levels by cohort. (A) Proportion of patients achieving NSAA levels of ≥0.1 IU/mL in course 1a. (B) Mean NSAA levels 48 and 72 hours after dose during course 1 by cohorta (efficacy analysis population). aError bars represent 95% CI calculated by the Wald method. Total number of patients for each course is represented by n; percentages were calculated with the number of patients for each course and schedule as the denominator.